首页 > 市场调查报告书 > 医疗设备

病患监测

市场调查报告书

商品编码

1606553

全球脉搏血氧计市场 - 2024-2031

Global Pulse Oximeter Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球脉搏血氧计市场规模达31.1亿美元，预计2031年将达到56.8亿美元，2024-2031年预测期间复合年增长率为7.9%。

脉搏血氧仪是一种非侵入性医疗设备，用于测量个别血液中的氧饱和度 (SpO2)。它通常连接在指尖上，透过使用光波长来评估血液中存在的氧合血红蛋白与脱氧血红蛋白的比率。脉搏血氧测定法在临床环境中的日益广泛使用已使其成为一种标准做法，通常被称为“第五生命体征”，与心率、血压、呼吸频率和体温等传统生命体征并列。

脉搏血氧仪的主要用途是提供即时、精确的血氧饱和度读数。对于健康个体，正常 SpO2 水平通常在 95% 到 100% 之间。读数低于此阈值可能表示潜在的健康问题，例如低氧血症，即血液中氧气不足。

脉搏血氧仪能够快速检测氧气水平的微小波动，使其成为紧急和重症监护环境中的重要工具。它们经常用于监测患有慢性阻塞性肺病、气喘和肺炎等呼吸系统疾病的患者，或在需要镇静的外科手术过程中进行监测。这些因素推动了全球脉搏血氧计市场的扩张。

市场动态：

驱动程式和限制

脉搏血氧计的技术进步

脉搏血氧计的技术进步极大地推动了全球脉搏血氧计市场的成长，预计这种成长将在整个市场预测期内持续下去。这些创新提高了脉搏血氧计的功能、准确性和用户友好性，使其对医疗保健提供者和患者越来越有吸引力。

现代脉搏血氧仪采用了复杂的演算法和讯号处理技术，可显着提高血氧饱和度 (SpO2) 读数的准确性。 Masimo 的讯号撷取技术 (SET) 等创新技术使设备即使在低血流量或病患移动等困难条件下也能提供可靠的测量。这种可靠性水准在临床环境中至关重要，精确监测对于病患安全至关重要。

ScienceDiect 研究出版物指出，脉搏血氧测定法是一种非侵入性光学方法，用于连续评估动脉血氧饱和度 (SpO2)。它被广泛认为是近年来患者监测领域最重要的进步之一。由于其操作简单、成本降低以及快速检测低氧血症的能力，脉搏血氧测定法已成为麻醉期间以及全球復健室和重症监护病房监测氧饱和度的标准。

穿戴式健康技术的发展催生了可连续佩戴的脉搏血氧计，从而能够即时监测生命征象。具有脉搏血氧测定功能的智慧手錶等设备有助于持续的健康跟踪，这对于管理慢性病和促进患者参与健康管理特别有益。

此外，关键参与者的策略（例如伙伴关係和协作）将推动脉搏血氧计市场的成长。例如，2023 年 1 月，飞利浦和 Masimo 宣布扩大合作伙伴关係，重点透过将 Masimo 新推出的 W1 智慧手錶整合到飞利浦的企业患者监护生态系统中来增强远距患者监护能力。此次合作旨在改善远距医疗应用，从而能够在家庭环境中对患者进行持续健康监测。所有这些因素都对全球脉搏血氧仪市场提出了需求。

此外，对与远距医疗解决方案整合的需求不断增长，有助于全球脉搏血氧仪市场的扩张。

产品召回

产品召回将阻碍全球脉搏血氧仪市场的成长。脉搏血氧仪市场的产品召回凸显了重大的安全问题，可能会对消费者信任和整体市场动态产生不利影响。一个值得注意的例子是 GE HealthCare 召回了超过 81,000 个 TruSignal 脉搏血氧饱和度感测器，这凸显了与故障设备相关的潜在危险。此次召回被 FDA 列为 I 类事件，显示这些设备可能对患者构成严重风险，包括可能导致医疗状况恶化甚至死亡。

此次召回是在发现某些 TruSignal 感测器可能故障后启动的，特别是在除颤等危急情况下。此类故障可能会妨碍除颤器向患者心臟输送必要能量的能力，这可能会在危及生命的紧急情况下阻碍基本治疗。

同样，2024 年 4 月，全球基金品质保证和合规团队收到了有关 Masimo Corporation 对某些 Rad-G 脉搏血氧计设备发起召回的紧急讯息。此次召回是由一项调查发现的一个重大问题引发的，其中一些设备可能会无意中改变其电源状态，这意味着它们可能会在用户不按下电源按钮的情况下关闭或打开。

Rad-G 脉搏血氧仪的问题在于它们意外关闭，这可能导致监测功能丧失。这种情况带来了严重的风险，特别是在临床环境中，持续监测患者对于及时进行医疗干预至关重要。因此，上述因素可能限制全球脉搏血氧仪市场的潜在成长。

有关此报告的更多详细资讯 - 索取样品

A pulse oximeter is a noninvasive medical device used to measure the oxygen saturation level (SpO2) in an individual's blood. Typically attached to a fingertip, it operates by employing light wavelengths to assess the ratio of oxygenated hemoglobin to deoxygenated hemoglobin present in the bloodstream. The growing use of pulse oximetry in clinical settings has established it as a standard practice, often referred to as the "fifth vital sign," alongside traditional vital signs such as heart rate, blood pressure, respiratory rate, and temperature.

The main purpose of a pulse oximeter is to deliver immediate and precise readings of blood oxygen saturation levels. For healthy individuals, normal SpO2 levels generally range from 95% to 100%. Readings falling below this threshold may indicate potential health concerns, such as hypoxemia, where there is inadequate oxygen in the blood.

Pulse oximeters are capable of quickly detecting even minor fluctuations in oxygen levels, making them essential tools in emergency and critical care environments. They are frequently employed to monitor patients with respiratory conditions such as COPD, asthma, and pneumonia or during surgical procedures requiring sedation. These factors have driven the global pulse oximeter market expansion.

Market Dynamics: Drivers & Restraints

Technological Advancements in Pulse Oximeters

Technological advancements in pulse oximeters are significantly driving the global pulse oximeter market's growth, which is expected to continue throughout the market forecast period. These innovations improve the functionality, accuracy, and user-friendliness of pulse oximeters, making them increasingly attractive to both healthcare providers and patients.

Modern pulse oximeters incorporate sophisticated algorithms and signal processing technologies that significantly enhance the accuracy of oxygen saturation (SpO2) readings. Innovations such as Masimo's Signal Extraction Technology (SET) allow devices to deliver reliable measurements even under difficult conditions, such as low blood flow or patient movement. This level of reliability is vital in clinical settings where precise monitoring is essential for patient safety.

As ScienceDitect research publication stated pulse oximetry is a noninvasive optical method used for the continuous evaluation of arterial oxygen saturation (SpO2). It is widely considered one of the most significant advancements in patient monitoring in recent years. Driven by its operational simplicity, decreasing costs, and the ability to swiftly detect hypoxemia, pulse oximetry has become the standard for monitoring oxygen saturation during anesthesia, as well as in recovery rooms and intensive care units globally.

The growth of wearable health technology has led to the creation of pulse oximeters that can be worn continuously, enabling real-time monitoring of vital signs. Devices like smartwatches that include pulse oximetry functions facilitate ongoing health tracking, which is especially beneficial for managing chronic conditions and promoting patient engagement in their health management.

Furthermore, key player's strategies such as partnerships and collaborations would drive this pulse oximeter market growth. For instance, in January 2023, Philips and Masimo announced an expansion of their partnership, focusing on enhancing remote patient monitoring capabilities through the integration of Masimo's newly launched W1 smartwatch into Philips' enterprise patient monitoring ecosystem. This collaboration aims to improve telehealth applications, allowing for continuous health monitoring of patients in home settings. All these factors demand the global pulse oximeter market.

Moreover, the rising demand for integration with telehealth solutions contributes to the global pulse oximeter market expansion.

Product Recalls

The product recalls will hinder the growth of the global pulse oximeter market. Product recalls in the pulse oximeter market underscore significant safety concerns that can adversely affect consumer trust and overall market dynamics. A notable instance is the GE HealthCare recall of over 81,000 TruSignal pulse oximetry sensors, which highlights the potential dangers associated with faulty devices. This recall was classified as a Class I event by the FDA, indicating that these devices could pose serious risks to patients, including the possibility of worsening medical conditions or even death.

The recall was initiated after it was discovered that some TruSignal sensors might malfunction, particularly during critical situations such as defibrillation. Such malfunctions could hinder the defibrillator's ability to deliver necessary energy to a patient's heart, potentially obstructing essential therapy during life-threatening emergencies.

Similarly, in April 2024, the Global Fund Quality Assurance and Compliance Team received urgent information regarding a recall initiated by Masimo Corporation for certain Rad-G Pulse Oximeter devices. The recall was prompted by an investigation that identified a significant issue some of these devices could unintentionally change their power state, meaning they might turn off or on without the user pressing the power button.

The problem with the Rad-G pulse oximeters involves them powering off unexpectedly, which can lead to a loss of monitoring capabilities. This situation poses serious risks, especially in clinical settings where continuous monitoring of patients is critical for timely medical intervention. Thus, the above factors could be limiting the global pulse oximeter market's potential growth.

For more details on this report - Request for Sample

Segment Analysis

The global pulse oximeter market is segmented based on Product Type, technology, component, age group, end-user, and region.

Product Type:

The portable pulse oximeter segment is expected to dominate the global pulse oximeter market share

The portable pulse oximeter segment currently holds a significant portion of the global pulse oximeter market and is expected to continue holding a significant portion during the forecast period.

This segment encompasses devices that are compact, user-friendly, and suitable for continuous monitoring of oxygen saturation levels across various environments, including hospitals, home care, and long-term care facilities. It is fueled by several key factors that enhance its appeal to both healthcare providers and consumers.

Portable pulse oximeters are designed for ease of use and portability, making them ideal for patients who need to monitor their oxygen levels outside clinical settings. Their compact design facilitates easy transport, allowing patients to track their health at home or while traveling. There are 3 types of portable pulse oximeters fingertip pulse oximeter, handheld pulse oximeter, and wearable pulse oximeter.

The growing trend towards home healthcare has significantly boosted the demand for portable pulse oximeters. As more individuals manage chronic conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma at home, the need for reliable monitoring devices has become crucial. Portable pulse oximeters offer a practical solution for self-monitoring oxygen saturation levels.

Furthermore, key player strategies such as partnerships and collaborations would drive this segment's growth in the pulse oximeter market. For instance, in November 2023, GE HealthCare and Masimo announced a collaboration to integrate Masimo SET Pulse Oximetry into GE HealthCare's Portrait Mobile platform, a wireless and wearable patient monitoring solution. This partnership aims to enhance patient monitoring capabilities, particularly in mobile settings, by leveraging Masimo's advanced pulse oximetry technology. These factors have solidified the segment's position in the global pulse oximeter market.

Geographical Analysis

North America is expected to hold a significant position in the global pulse oximeter market share

North America holds a substantial position in the global pulse oximeter market and is expected to hold most of the market share.

The region has a high incidence of chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. This prevalence drives the demand for effective monitoring solutions like pulse oximeters, which are essential for managing these conditions.

According to the Centers for Disease Control and Prevention (CDC) data in 2021, over 15 million Americans (approximately 6.4%) reported being diagnosed with Chronic Obstructive Pulmonary Disease (COPD). This condition is associated with several major risk factors, including tobacco smoking, occupational and environmental exposures, respiratory infections, and genetic predispositions. The prevalence of COPD can be assessed both in crude terms and through age-adjusted statistics, reflecting its significant impact on public health in the U.S. All these factors demand the global pulse oximeter market.

Furthermore, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, product launches & approvals, and collaborations & partnerships would propel the pulse oximeter market growth. For instance, in February 2024, Masimo Corporation announced the FDA clearance of its MightySat Medical, marking it as the first and only FDA-cleared medical fingertip pulse oximeter available for purchase over-the-counter (OTC) without a prescription. The FDA granted 510(k) clearance to MightySat Medical after determining that it is substantially equivalent to a previously cleared prescription device from Masimo.

Also, in March 2024, Movano Health completed a hypoxia trial in collaboration with the University of California, San Francisco (UCSF), which yielded promising results regarding the accuracy of its Evie Ring pulse oximeter. This trial confirmed that the Evie Ring's blood oxygen saturation (SpO2) measurements exceed the accuracy guidelines set by the U.S. Food and Drug Administration (FDA).

Similarly, in May 2024, Masimo announced the FDA clearance for its new baby monitoring system called Stork, designed specifically for healthy infants aged 0 to 18 months. This innovative device allows parents and caregivers to monitor key vital signs without the need for a prescription, making it accessible for home use. Thus, the above factors are consolidating the region's position as a dominant force in the global pulse oximeter market.

Asia Pacific is growing at the fastest pace in the global pulse oximeter market share

Asia Pacific holds the fastest pace in the global pulse oximeter market and is expected to hold most of the market share.

The rise in respiratory conditions, particularly chronic obstructive pulmonary disease (COPD) and asthma, significantly boosts the demand for pulse oximeters. These devices are crucial for monitoring blood oxygen levels and essential for managing respiratory health effectively. The World Health Organization has reported that COPD is a leading cause of death globally, with a substantial burden falling on low- and middle-income countries where the need for monitoring tools is critical.

The Asian Development Bank's report, data in November 2022, "Strengthening Oxygen Systems in Asia and the Pacific," emphasizes the vital importance of pulse oximeters in pneumonia treatment, especially for children. It highlights that effective oxygen therapy and monitoring are crucial for managing pneumonia, which remains a leading cause of illness and death among young children.

A meta-analysis of oxygen improvement programs referenced in the report shows significant advantages linked to the use of pulse oximetry in pneumonia treatment. Notably, it indicates a 48% decrease in hospital mortality rates from pneumonia in children under five years old. This statistic underscores how timely and precise monitoring of oxygen levels can greatly enhance survival rates for this vulnerable age group.

Countries like China and India are experiencing rapid population growth alongside an aging demographic that is more vulnerable to chronic diseases. This demographic shift increases the demand for medical devices such as pulse oximeters, which facilitate ongoing health monitoring in both hospital and home care settings.

Furthermore, key players in the industry product launches that would drive this global pulse oximeter market growth. For instance, in February 2023, Heal Force introduced the FS-E2 Pulse Oximeter, a new product designed to effectively meet the blood oxygen saturation detection needs of residents, particularly elderly patients. This device is capable of real-time monitoring of blood oxygen saturation and pulse rate, allowing for timely detection of silent hypoxic symptoms in older adults in China.

Also, in October 2022, Max Ventilator is poised to introduce a range of new medical devices, including a pulse oximeter, ECG monitors, and other patient monitoring solutions. This initiative reflects the company's recognition of the growing demand for smart and innovative devices in the healthcare sector, aiming to enhance patient care and monitoring capabilities in India. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global pulse oximeter market.

Competitive Landscape

The major global players in the pulse oximeter market include Masimo., Medtronic plc, Koninklijke Philips N.V., Nonin., NIHON KOHDEN CORPORATION., GE Healthcare, CONTEC MEDICAL SYSTEMS CO., LTD, ChoiceMMed, Dragerwerk AG & Co. KGaA, and ICU Medical, Inc. among others.

Key Developments

In August 2024, Prevounce Health launched its first blood oxygen device for remote patient monitoring (RPM), named the Pylo OX1-LTE. This new pulse oximeter is designed to enhance the management of patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD) and asthma, as well as other health scenarios that require continuous monitoring, and treatments that necessitate heart rate tracking.
In May 2024, Masimo announced a partnership with Medable Inc. to integrate its medical-grade wearable devices into clinical research. This collaboration involves the incorporation of Masimo's MightySat Rx pulse oximeter into Medable's evidence-generation platform for eight large-scale pharmaceutical clinical trials focused on two oncology indications breast cancer and lung cancer.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global pulse oximeter market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Component
3.4. Snippet by Age Group
3.5. Snippet by End-User
3.6. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological Advancements in Pulse Oximeters
- 4.1.2. Restraints
  - 4.1.2.1. Product Recalls
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Product Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Portable Pulse Oximeter*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Fingertip Pulse Oximeter
- 6.2.4. Handheld Pulse Oximeter
- 6.2.5. Wearable Pulse Oximeter
6.3. Tabletop/Bedside Pulse Oximeter

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Conventional Devices*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Connected Devices

8. By Component

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 8.1.2. Market Attractiveness Index, By Component
8.2. Monitors*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Sensors

9. By Age Group

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 9.1.2. Market Attractiveness Index, By Age Group
9.2. Adults*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Pediatrics

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Homecare Settings
10.4. Ambulatory Surgical Centers
10.5. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.8.1. U.S.
  - 11.2.8.2. Canada
  - 11.2.8.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.8.1. Germany
  - 11.3.8.2. U.K.
  - 11.3.8.3. France
  - 11.3.8.4. Spain
  - 11.3.8.5. Italy
  - 11.3.8.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.8.1. Brazil
  - 11.4.8.2. Argentina
  - 11.4.8.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.8.1. China
  - 11.5.8.2. India
  - 11.5.8.3. Japan
  - 11.5.8.4. South Korea
  - 11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Masimo.*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Medtronic plc
13.3. Koninklijke Philips N.V.
13.4. Nonin.
13.5. NIHON KOHDEN CORPORATION.
13.6. GE Healthcare
13.7. CONTEC MEDICAL SYSTEMS CO., LTD
13.8. ChoiceMMed
13.9. Dragerwerk AG & Co. KGaA
13.10. ICU Medical, Inc.

LIST NOT EXHAUSTIVE